MT Højgaard Holding A/S
29.1.2021 15:48:38 CET | Globenewswire | Press release
MT Højgaard Holding’s business unit, Enemærke & Petersen, has won the Funen-based social housing organisation Civica’s tender for a multi-year strategic partnership for renovation and construction projects comprising an estimated total value of DKK 3 billion. It is expected that Civica will enter into the agreement with Enemærke & Petersen after the end of the standstill period.
Enemærke & Petersen will perform the work in close cooperation with Erik Arkitekter A/S, Oluf Jørgensen A/S, SWECO Danmark A/S, Kant Arkitekter and Bymunch By- og Landskabsdesign ApS.
The tender does not change MT Højgaard Holding’s previously announced 2020 outlook, but it will contribute significantly to the group’s long-term, sustainable development in the coming years. MT Højgaard Holding will publish its annual report 2020 and the outlook for 2021 on 24 February 2021.
Additional information:
CEO Morten Hansen and CFO Martin Solberg can be contacted on telephone +45 22 70 93 65.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
